Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1Leiomyoma 1Breast Neoplasms 1Agnosia 1

Interventions

Ropivacaine 2Magnesium Sulfate 2Fentanyl 2trimebutine 3-thiocarbamoylbenzenesulfonate 1ramosetron 1Transdermal Patch 1Tablets 1Surveys and Questionnaires 1Psilocybin 1Pregabalin 1Nefopam 1Morphine 1Lidocaine 1Levobupivacaine 1Ketoprofen 1Ketamine 1Injections, Subcutaneous 1High-Energy Shock Waves 1Control Groups 1Capsaicin 1Bupivacaine 1Botulinum Toxins, Type A 1Anesthetics, Local 1Analgesics, Opioid 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Agnosia × Injections, Subcutaneous × Clear all
NCT02270255 2019-08-14

Superior Hypogastric Nerve Block for Pain Control Post-uterine Fibroid Embolization

McGill University Health Centre/Research Institute of the McGill University Health Centre

Phase 2 Completed
44 enrolled 8 charts

Agnosia, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡